Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 372 clinical trials
Featured trial
Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

> Navitoclax is an investigational drug (not yet approved) being developed for the treatment of MF. The study has 2 arms - A and B. In Arm A, participants will receive navitoclax in combination with

  • 835 views
  • 10 Aug, 2022
  • 226 locations
Featured trial
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

assessment of change in spleen volume when compared to ruxolitinib in participants with myelofibrosis. Navitoclax is an investigational drug for the treatment of myelofibrosis. Participants in

  • 380 views
  • 18 Sep, 2022
  • 150 locations
Featured trial
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

Our team of medical professionals is evaluating an investigational drug that is designed to slow the progression of Alzheimer’s disease. The study drug, ALZ-801, is a tablet that is taken twice

mild dementia
mini-mental state examination
apolipoprotein e
dementia
  • 76 views
  • 20 Sep, 2022
  • 79 locations
Featured trial
Study to Assess the Efficacy Safety and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-2)  

Primary Objective: Primary population (former smokers cohort): Evaluate the efficacy of itepekimab compared with placebo on the annualized rate of acute moderate-or-severe COPD exacerbations in former smokers with moderate-to-severe COPD Secondary Objectives: Primary population (former smokers cohort): Evaluate the efficacy of itepekimab compared with placebo on pulmonary function in former …

  • 662 views
  • 26 Sep, 2022
  • 56 locations
Featured trial
Narcolepsy with or without Cataplexy

Do you suffer from excessive daytime sleepiness associated with Narcolepsy?Would you like to try a new investigational drug for Narcolepsy? If you or a loved one suffers from Narcolepsy with or

somnolence
experimental drug
excessive daytime sleepiness
cataplexy
body mass index
  • 20 views
  • 07 Mar, 2022
  • 1 location
Featured trial
Post-Traumatic Stress Disorder

A clinical research study of an investigational drug for adults with Post‐Traumatic Stress Disorder (PTSD).

  • 23 views
  • 16 Mar, 2022
  • 1 location
Featured trial
Non-Erosive Gastroesophageal Reflux Disease

DIAGNOSED WITH GASTROPARESIS?Now enrolling volunteers in a research study testing the safety andeffectiveness of an investigational drug for individuals withgastroparesis.

  • 6 views
  • 23 Mar, 2022
  • 1 location
Featured trial
Atopic Dermatitis

The OXFORAD™ Study will determine how well an investigational drug works in treating people with moderate-to-severe eczema (atopic dermatitis).  

  • 132 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Yeast Infections

DO YOU HAVE A YEAST INFECTION? Consider a clinical research study testing the safety and effectiveness of an investigational drug for women with vulvovaginal candidiasis.

  • 0 views
  • 07 Jul, 2022
  • 1 location
Featured trial
GAIN: GingipAIN Inhibitor for Treatment of Alzheimer's Disease

GAIN is a clinical trial evaluating whether an investigational drug is safe and can stop the progression of Alzheimer’s Disease by reducing bacterial damage in the brain. The P

senile plaques
  • 153 views
  • 08 Dec, 2020
  • 1 location